![]() |
Name |
penicillol B
|
Molecular Formula | C15H16O6 | |
IUPAC Name* |
8-hydroxy-6-methoxy-6'-methylspiro[4H-isochromene-3,2'-oxane]-1,4'-dione
|
|
SMILES |
COc1cc(O)c2c(c1)CC1(CC(=O)CC(C)O1)OC2=O
|
|
InChI |
InChI=1S/C15H16O6/c1-8-3-10(16)7-15(20-8)6-9-4-11(19-2)5-12(17)13(9)14(18)21-15/h4-5,8,17H,3,6-7H2,1-2H3/t8-,15-/m0/s1
|
|
InChIKey |
YJZRXAXZEZDGEJ-AYVTZFPOSA-N
|
|
Synonyms |
NA
|
|
CAS | NA | |
PubChem CID | NA | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Molecular Weight: | 292.29 | ALogp: | 1.6 |
HBD: | 1 | HBA: | 6 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 82.1 | Aromatic Rings: | 3 |
Heavy Atoms: | 21 | QED Weighted: | 0.798 |
Caco-2 Permeability: | -4.592 | MDCK Permeability: | 0.00002020 |
Pgp-inhibitor: | 0.002 | Pgp-substrate: | 0.002 |
Human Intestinal Absorption (HIA): | 0.007 | 20% Bioavailability (F20%): | 0.058 |
30% Bioavailability (F30%): | 0.983 |
Blood-Brain-Barrier Penetration (BBB): | 0.163 | Plasma Protein Binding (PPB): | 75.76% |
Volume Distribution (VD): | 0.736 | Fu: | 10.40% |
CYP1A2-inhibitor: | 0.39 | CYP1A2-substrate: | 0.625 |
CYP2C19-inhibitor: | 0.218 | CYP2C19-substrate: | 0.785 |
CYP2C9-inhibitor: | 0.192 | CYP2C9-substrate: | 0.778 |
CYP2D6-inhibitor: | 0.047 | CYP2D6-substrate: | 0.669 |
CYP3A4-inhibitor: | 0.531 | CYP3A4-substrate: | 0.323 |
Clearance (CL): | 15.453 | Half-life (T1/2): | 0.735 |
hERG Blockers: | 0.018 | Human Hepatotoxicity (H-HT): | 0.361 |
Drug-inuced Liver Injury (DILI): | 0.911 | AMES Toxicity: | 0.208 |
Rat Oral Acute Toxicity: | 0.061 | Maximum Recommended Daily Dose: | 0.124 |
Skin Sensitization: | 0.13 | Carcinogencity: | 0.028 |
Eye Corrosion: | 0.004 | Eye Irritation: | 0.096 |
Respiratory Toxicity: | 0.291 |